Filing Details

Accession Number:
0001203311-23-000121
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-11-13 19:32:35
Reporting Period:
2023-11-09
Accepted Time:
2023-11-13 19:32:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1060736 Seagen Inc. SGEN Biological Products, (No Disgnostic Substances) (2836) 911874389
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1361966 B Vaughn Himes 21823 30Th Drive Se
Bothell WA 98021
Chief Technical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-11-09 8,567 $213.31 42,792 No 4 S Direct
Common Stock Disposition 2023-11-09 218 $213.88 42,574 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 119,471 Indirect by Trust
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a written plan, entered into on November 29, 2022, that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
  2. Reflects sales of common stock executed in multiple transactions at prices ranging from $212.79 to $213.72. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
  3. Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.